Revitalist

What Revitalist does

Revitalist operates a multi-location, direct-to-consumer ketamine therapy and mental health clinic business headquartered in Knoxville, Tennessee, with additional sites in Johnson City, TN and Tampa/Clearwater, FL. The company was founded in 2018 by Kathryn Walker, who holds MSN degrees in both Anesthesia and Psychiatry, and serves patients with treatment-resistant depression, PTSD, anxiety, OCD, bipolar disorder, chronic pain syndromes, suicidal ideation, and co-occurring substance use disorders. Its core clinical offering is IV ketamine infusion therapy, which leverages ketamine's NMDA/glutamate receptor mechanism to produce rapid symptom relief within hours, in contrast to the weeks-to-months onset typical of traditional SSRIs and SNRIs. Revitalist supplements this with Spravato (esketamine nasal spray, FDA-approved 2019 and insurance-reimbursable), Ketamine-Assisted Psychotherapy combining infusions with therapist integration, supervised at-home ketamine therapy, IV vitamin infusions, and a neuropeptide therapy line targeting trauma circuits at the cellular level.

The business runs on a hybrid cash-pay and insurance-reimbursement model: ketamine infusions and adjunct services are paid out-of-pocket or via monthly membership and per-visit plans, while Spravato is billed through participating insurers including Wellpoint. Patient acquisition is driven by content marketing (blog, podcast, social), a free initial assessment funnel, and a dedicated provider referral program for healthcare professionals and first-responder organizations. The company self-reports an 80% success rate across treatment-resistant cases and an 87% profound trauma healing rate among Johnson City PTSD patients, though these are not externally validated. Disclosed financial history shows revenue of approximately $2.07M in 2021 and $4.57M in 2022, funded by roughly $5.14M in combined equity raises, while operating losses remained substantial at approximately -$11M EBITDA in 2022, reflecting heavy reinvestment into clinic buildout, geographic expansion, and new product development.

Name

Revitalist

Legal name

Revitalist

Website

https://revitalist.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Revitalist is a multi-location U.S. ketamine therapy clinic operator, founded in 2018 and led by CEO Kathryn Walker, that delivers IV ketamine infusions, Spravato, neuropeptide therapy, and related treatments to patients with treatment-resistant depression, PTSD, chronic pain, and other conditions across clinics in Tennessee and Florida.

Ownership category

akta.pro rank

Product category

Ketamine Therapy and Mental Health Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (62142), Offices of Physicians, Mental Health Specialists (621112)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Outpatient Mental Health Clinics & Counseling Centers (HLAFACAA)

akta.pro secondary industry

Outpatient Mental Health & Counseling Clinics (HLAFABAC)

Keywords

• Ketamine therapy
• Mental health treatments
• Chronic pain management
• Esketamine treatment
• Iv vitamin infusions

Headquarters

HQ city

Knoxville

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Ketamine Infusion Therapy: IV ketamine treatments administered in clinic for mental health and chronic pain conditions. Patients pay per infusion or through treatment packages. Initial series typically involves 6 infusions over 2-3 weeks.
2. Spravato (Esketamine) Treatment: Insurance-covered nasal spray treatment for treatment-resistant depression. Revenue collected through insurance reimbursement and patient co-pays.
3. Vitamin Infusion Therapy: IV vitamin therapy services for wellness, hydration, and nutrient supplementation. Offered as standalone treatments or integrated with ketamine protocols.
4. Neuropeptide Therapy: Cellular-level peptide treatments for stress response regulation and trauma recovery. Offered as specialized treatment protocols.
5. Membership/Package Plans: Monthly membership and pay-as-you-go pricing options providing equitable and accessible care with flexible payment structures.
6. Provider Referrals: Referral network from healthcare providers sending patients for specialized ketamine and mental health treatments.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Revitalist operates multi-location ketamine therapy clinics that administer IV ketamine infusions, Spravato (esketamine) nasal spray, ketamine-assisted psychotherapy, IV vitamin therapy, and neuropeptide therapy. The clinics serve patients suffering from treatment-resistant depression, anxiety, PTSD, OCD, chronic pain syndromes, and suicidal ideation across three locations in Tennessee and Florida. The company also provides supervised at-home ketamine therapy for patients unable to visit a clinic.

Product overview

Revitalist Clinic operates a multi-location ketamine therapy practice offering a portfolio of breakthrough mental health and pain treatments. The core offerings include IV Ketamine Therapy (the flagship treatment), Home Ketamine Therapy, and Ketamine Assisted Psychotherapy — all utilizing ketamine's NMDA/glutamate mechanism for rapid neuroplasticity and symptom relief. The company also provides Spravato® (FDA-approved esketamine nasal spray) for treatment-resistant depression, IV Vitamin Infusion Therapy for wellness support, and Neuropeptide Therapy for cellular-level trauma recovery. The clinic treats conditions including depression, anxiety, PTSD, OCD, bipolar disorder, chronic pain, suicidal ideation, and substance abuse across three locations in Tennessee and Florida.

Differentiator

Problem solved

Functional benefit

Products and services

• Ketamine Therapy IV infusion therapy utilizing FDA-approved ketamine to provide rapid symptom relief for treatment-resistant depression, anxiety, PTSD, OCD, bipolar disorder, chronic pain, and suicidal ideation by modulating the NMDA/glutamate system and promoting neuroplasticity.
• Home Ketamine Therapy Supervised ketamine therapy delivered safely in the patient's own home with medical oversight, providing convenient access for patients unable to travel to clinic locations.
• Ketamine Assisted Psychotherapy Combination of ketamine infusion with a trained therapist present during or immediately after sessions to help patients process insights and emotions for enhanced treatment outcomes.
• Spravato (Esketamine) FDA-approved nasal spray treatment using esketamine for treatment-resistant depression, covered by insurance and providing rapid symptom improvement for patients who have not responded to conventional antidepressants.
• Vitamin Infusions (IV Vitamin Infusion Therapy) IV therapy delivering essential nutrients and vitamins directly into the bloodstream for maximum absorption, supporting wellness goals including migraine relief, immune strengthening, energy optimization, and recovery.
• Neuropeptide Therapy Peptide treatments operating at the cellular level to regulate stress response, calm hyperactive trauma circuits, and support comprehensive PTSD and mental health recovery.
• Supplements Nutritional supplements offered to support patient health and complement treatment outcomes.

Quantifiable outcome

• 80% success rate for ketamine therapy in treatment-resistant conditions
• +3 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• KetaMD: Telehealth-led ketamine therapy company offering at-home treatments for depression, anxiety, and chronic pain. Overlaps with Revitalist on patient indications and the at-home ketamine service.
• Better U (formerly BetterHelp-affiliated ketamine programs): DTC ketamine therapy platform offering at-home and clinic-based treatment protocols for mental health; comparable consumer positioning and subscription/membership pricing model.
• Austin Ketamine Clinic: Independent outpatient ketamine infusion clinic treating depression, PTSD, and chronic pain. Comparable single/regional operator with similar treatment menu and patient mix.
• Field Trip Health: Operated a network of ketamine-assisted psychotherapy clinics across North America focused on mental health; same patient population, same protocol-based IV ketamine offering, same outpatient clinic model.
• Actify Neurotherapies: Network of outpatient clinics offering ketamine infusion therapy and other neurotherapies for depression and chronic pain; comparable clinical model and outpatient specialty positioning.
• Mindbloom: Direct-to-consumer ketamine therapy provider offering at-home and clinic-based treatments for depression, anxiety, and PTSD. Highly comparable in treatment menu, patient positioning, and D2C GTM motion.
• Nue Life Health: Telehealth and clinic-based ketamine therapy provider for treatment-resistant depression, anxiety, and PTSD; directly comparable outpatient ketamine-assisted psychotherapy service line.

Broad incumbents

• Compass Pathways: Clinical-stage psychedelic therapy company developing psilocybin treatment for treatment-resistant depression. Not a direct service competitor but a leading incumbent shaping the broader ketamine/psychedelic-assisted therapy market.
• Janssen Pharmaceuticals (Spravato / esketamine): Manufacturer of Spravato (esketamine), the FDA-approved nasal spray Revitalist administers. A large incumbent that defines the REMS-constrained treatment environment and shapes payer policy for ketamine-assisted care.

Regional players

• Cedar Psychiatry: Multi-location ketamine therapy and interventional psychiatry provider in the Western U.S. Overlapping outpatient ketamine clinic model and similar patient indications, but serves a different regional footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/revitalistcorp
• Facebookfacebook.com/RevitalistLifestyleandWellnessLtd
• LinkedInlinkedin.com/company/revitalist-lifestyle-and-wellness-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Revitalist